back to
back to
Back to video list

The current role of PD-1 inhibition in the treatment of relapsed or refractory classical Hodgkin Lymphoma

Speaker

Bastian von Tresckow

Session

Checkpoint Inhibition in Hodgkin Lymphoma – State of the art and future perspectives

Others Talks of this Session